Novo Nordisk A/S (NOVO-B)

Track

The most recent insider trading activity at Novo Nordisk A/S occurred on February 10, 2026. During the period from November 2025 to February 2026, multiple executives, including the CFO and CSO, executed sell transactions. These sales followed a mix of buy and sell activity by board members and operational leadership earlier in the period.

Recent historical selling signal · Feb 2026

Not featured in screeners

Featured in screeners

Recent historical selling signal · Feb 2026

Not featured in screeners

Ticker: NOVO-B Exchange: CPH

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Insider activity signal detected

2 activity signals detected for Novo Nordisk A/S

Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Novo Nordisk A/S. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Trades

Karsten Munk Knudsen

Executive Vice President, Chief Financial Officer (CFO)

2 sales — total 8,381,420 DKK

Sale 10 Feb 2026

Value DKK1,736,521.90 | Price 40.00 | Shares 28,623

Sale 10 Feb 2026

Value DKK4,862,026.37 | Price 258.37 | Shares 40,249

Martin Holst Lange

Executive Vice President, R&D and Chief Scientific Officer (CSO)

1 sale — total 7,035,600 DKK

Sale 9 Feb 2026

Value DKK1,566,311.22 | Price 467.93 | Shares 86,554

Emil Kongshøj Larsen

Executive Vice President, International Operations

1 sale — total 1,110,721 DKK

Sale 4 Feb 2026

Value DKK1,110,720.73 | Price 304.72 | Shares 3,645

David Moore

Executive Vice President, US Operations

1 sale — total 2,085,839 DKK

Sale 4 Feb 2026

Value DKK2,085,839.07 | Price 304.72 | Shares 6,845

Stephan Engels

Member of the Board of Directors

1 purchase — total 2,015,625 DKK

Buy 17 Nov 2025

Value DKK2,015,625.00 | Price 312.50 | Shares 6,450

David Moore

Executive Vice President, US Operations

1 buy, 1 sell — total 2,431,302 DKK

Sale 10 Nov 2025

Value DKK2,431,301.74 | Price 297.95 | Shares 8,160

Buy 10 Nov 2025

Value DKK0.00 | Price 0.00 | Shares 18,634

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2026-02-11	2026-02-10	S Sale	2.9 Karsten Munk Knudsen Executive Vice President, Chief Financial Officer (CFO) Officer	28,623 40.00 DKK1,736,522	28,623	40.00	DKK1,736,522
2026-02-11	2026-02-10	S Sale	2.9 Karsten Munk Knudsen Executive Vice President, Chief Financial Officer (CFO) Officer	40,249 258.37 DKK4,862,026	40,249	258.37	DKK4,862,026
2026-02-10	2026-02-09	S Sale	3.0 Martin Holst Lange Executive Vice President, R&D and Chief Scientific Officer (CSO) Officer	86,554 467.93 DKK1,566,311	86,554	467.93	DKK1,566,311
2026-02-05	2026-02-04	S Sale	2.9 Emil Kongshøj Larsen Executive Vice President, International Operations Officer	3,645 304.72 DKK1,110,721	3,645	304.72	DKK1,110,721
2026-02-05	2026-02-04	S Sale	2.8 David Moore Executive Vice President, US Operations Officer	6,845 304.72 DKK2,085,839	6,845	304.72	DKK2,085,839
2025-11-17	2025-11-17	B Purchase	1.0 Stephan Engels Member of the Board of Directors Executive Director	6,450 312.50 DKK2,015,625	6,450	312.50	DKK2,015,625
2025-11-11	2025-11-10	S Sale	2.8 David Moore Executive Vice President, US Operations Officer	8,160 297.95 DKK2,431,302	8,160	297.95	DKK2,431,302
2025-11-11	2025-11-10	B Purchase	2.8 David Moore Executive Vice President, US Operations Officer	18,634 0.00 DKK0	18,634	0.00	DKK0